These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22560521)

  • 1. Ten recommendations for closing the credibility gap in reporting industry-sponsored clinical research: a joint journal and pharmaceutical industry perspective.
    Mansi BA; Clark J; David FS; Gesell TM; Glasser S; Gonzalez J; Haller DG; Laine C; Miller CL; Mooney LA; Zecevic M
    Mayo Clin Proc; 2012 May; 87(5):424-9. PubMed ID: 22560521
    [No Abstract]   [Full Text] [Related]  

  • 2. Commenting on ten recommendations for closing the credibility gap in reporting industry-sponsored clinical research.
    Stossel TP; Stell LK
    Mayo Clin Proc; 2012 Sep; 87(9):925-6; author reply 926. PubMed ID: 22958997
    [No Abstract]   [Full Text] [Related]  

  • 3. Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials.
    Matcham J; Julious S; Pyke S; O'Kelly M; Todd S; Seldrup J; Day S
    Pharm Stat; 2011; 10(1):70-3. PubMed ID: 20187020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Credibility of industry-sponsored clinical research: hype or hope?
    Braillon A
    Mayo Clin Proc; 2012 Sep; 87(9):925. PubMed ID: 22958998
    [No Abstract]   [Full Text] [Related]  

  • 5. Comments on 'The potential for bias in the reporting of industry sponsored clinical trials' by Stephen Pyke et al. and 'Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry sponsored clinical trials' by James Matcham et al. Pharmaceutical Statistics.
    Campbell MJ
    Pharm Stat; 2011; 10(1):80-1. PubMed ID: 21275038
    [No Abstract]   [Full Text] [Related]  

  • 6. Transparency and credibility of industry-sponsored clinical trial publications: a survey of journal editors.
    Mooney LA; Fay L; DeCastro B; Zanki TA; Mansi B
    Curr Med Res Opin; 2019 Jul; 35(7):1221-1230. PubMed ID: 30648455
    [No Abstract]   [Full Text] [Related]  

  • 7. [Publication ethics: regulation of financial conflicts of interests in medical journals].
    Kakuk P
    Lege Artis Med; 2011 Jan; 21(1):65-71. PubMed ID: 21469379
    [No Abstract]   [Full Text] [Related]  

  • 8. [Knowledge on feet of clay].
    Dahlqvist R
    Lakartidningen; 2008 May 7-13; 105(19):1405-6. PubMed ID: 18574980
    [No Abstract]   [Full Text] [Related]  

  • 9. Promoting transparency in pharmaceutical industry-sponsored research.
    Ross JS; Gross CP; Krumholz HM
    Am J Public Health; 2012 Jan; 102(1):72-80. PubMed ID: 22095335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Industry-sponsored clinical research: a broken system.
    Angell M
    JAMA; 2008 Sep; 300(9):1069-71. PubMed ID: 18768418
    [No Abstract]   [Full Text] [Related]  

  • 11. The sins of ghostwriting.
    Somberg JC
    Am J Ther; 2008; 15(4):297-8. PubMed ID: 18645328
    [No Abstract]   [Full Text] [Related]  

  • 12. Ghost management: how much of the medical literature is shaped behind the scenes by the pharmaceutical industry?
    Sismondo S
    PLoS Med; 2007 Sep; 4(9):e286. PubMed ID: 17896859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical research: paradox, challenge or dilemma?
    Sheikh AL
    East Mediterr Health J; 2006; 12 Suppl 1():S42-9. PubMed ID: 17037688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trust in the medical literature--and Viewpoints in JAMA Internal Medicine.
    Steinbrook R; Redberg RF
    JAMA Intern Med; 2013 Jun; 173(12):1047-8. PubMed ID: 23609117
    [No Abstract]   [Full Text] [Related]  

  • 15. Industry-funded breast cancer trials show more positive results.
    Gardner A
    Int J Health Serv; 2007; 37(3):591-3. PubMed ID: 17844937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Access to data from clinical trials sponsored by pharmaceutical companies.
    West R
    Addiction; 2007 May; 102(5):682-3. PubMed ID: 17493100
    [No Abstract]   [Full Text] [Related]  

  • 17. Between the lines: navigating the uncharted territory of industry-sponsored research.
    Davidoff F
    Health Aff (Millwood); 2002; 21(2):235-42. PubMed ID: 11900164
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ghostwriting].
    Haug C
    Tidsskr Nor Laegeforen; 2008 May; 128(9):1039. PubMed ID: 18451881
    [No Abstract]   [Full Text] [Related]  

  • 19. Full-disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors.
    Rifai N; Plebani M; Wu AH; Delanghe J; Brugnara C; Delvin E; Lamb EJ; Ness PM; Wick MR; Berg JP
    Clin Chim Acta; 2011 Mar; 412(7-8):491-2. PubMed ID: 21159312
    [No Abstract]   [Full Text] [Related]  

  • 20. Awareness and enforcement of guidelines for publishing industry-sponsored medical research among publication professionals: the Global Publication Survey.
    Wager E; Woolley K; Adshead V; Cairns A; Fullam J; Gonzalez J; Grant T; Tortell S
    BMJ Open; 2014 Apr; 4(4):e004780. PubMed ID: 24747794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.